These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

886 related items for PubMed ID: 24360587

  • 1. The effect of graft configuration on 30-day failure of infrapopliteal bypasses.
    Nguyen BN, Neville RF, Abugideiri M, Amdur R, Sidawy AN.
    J Vasc Surg; 2014 Apr; 59(4):1003-8. PubMed ID: 24360587
    [Abstract] [Full Text] [Related]

  • 2. Alternative conduit for infrageniculate bypass in patients with critical limb ischemia.
    Moreira CC, Leung AD, Farber A, Rybin D, Doros G, Siracuse JJ, Kalish J, Eslami MH.
    J Vasc Surg; 2016 Jul; 64(1):131-139.e1. PubMed ID: 27345506
    [Abstract] [Full Text] [Related]

  • 3. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia.
    Arvela E, Söderström M, Albäck A, Aho PS, Venermo M, Lepäntalo M.
    J Vasc Surg; 2010 Sep; 52(3):616-23. PubMed ID: 20615645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass.
    McPhee JT, Barshes NR, Ozaki CK, Nguyen LL, Belkin M.
    J Vasc Surg; 2012 Apr; 55(4):1008-14. PubMed ID: 22365176
    [Abstract] [Full Text] [Related]

  • 8. Broad variation in prosthetic conduit use for femoral-popliteal bypass is not justified on the basis of contemporary outcomes favoring autologous great saphenous vein.
    Humbarger O, Siracuse JJ, Rybin D, Stone DH, Goodney PP, Schermerhorn ML, Farber A, Jones DW, Vascular Quality Initiative.
    J Vasc Surg; 2019 Nov; 70(5):1514-1523.e2. PubMed ID: 31147137
    [Abstract] [Full Text] [Related]

  • 9. Comparison of graft patency, limb salvage, and antithrombotic therapy between prosthetic and autogenous below-knee bypass for critical limb ischemia.
    Suckow BD, Kraiss LW, Stone DH, Schanzer A, Bertges DJ, Baril DT, Cronenwett JL, Goodney PP, Vascular Study Group of New England.
    Ann Vasc Surg; 2013 Nov; 27(8):1134-45. PubMed ID: 24011814
    [Abstract] [Full Text] [Related]

  • 10. Comparison of propaten heparin-bonded vascular graft with distal anastomotic patch versus autogenous saphenous vein graft in tibial artery bypass.
    Kaisar J, Chen A, Cheung M, Kfoury E, Bechara CF, Lin PH.
    Vascular; 2018 Apr; 26(2):117-125. PubMed ID: 28835186
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A, Eckstein HH, Peripheral Bypass Grafting: Prospective Evaluation of FUSION Vascular Graft for Above Knee Targets (PERFECTION) Study Group.
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [Abstract] [Full Text] [Related]

  • 13. Impact of tibial bypass conduit on long-term amputation-free survival and primary patency in the Vascular Quality Initiative.
    Dalmia V, Carnevale M, Friedmann P, Indes J, Lipsitz E, Futchko J, Koleilat I.
    J Vasc Surg; 2022 Apr; 75(4):1351-1357.e2. PubMed ID: 34788646
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.
    Arvela E, Venermo M, Söderström M, Albäck A, Lepäntalo M.
    Ann Vasc Surg; 2012 Apr; 26(3):396-403. PubMed ID: 22285375
    [Abstract] [Full Text] [Related]

  • 16. Alloplastic bypass material below the knee: actual rationale.
    Debus ES, Larena-Avellaneda A, Heimlich F, Goertz J, Fein M.
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):159-66. PubMed ID: 23443601
    [Abstract] [Full Text] [Related]

  • 17. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency.
    Fichelle JM, Marzelle J, Colacchio G, Gigou F, Cormier F, Cormier JM.
    Ann Vasc Surg; 1995 Mar; 9(2):187-96. PubMed ID: 7786705
    [Abstract] [Full Text] [Related]

  • 18. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.
    Brumberg RS, Back MR, Armstrong PA, Cuthbertson D, Shames ML, Johnson BL, Bandyk DF.
    J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227
    [Abstract] [Full Text] [Related]

  • 19. Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass.
    Bellosta R, Natalini G, Luzzani L, Carugati C, Sarcina A.
    Ann Vasc Surg; 2013 Feb; 27(2):218-24. PubMed ID: 23092735
    [Abstract] [Full Text] [Related]

  • 20. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH, Morales R, Showalter DP, Lepore MR, Nair DG.
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.